CNS PHARMACEUTICALS INC COM
CNS PHARMACEUTICALS INC COM is a security (CUSIP 18978H508) tracked across SEC portfolio filings. 9 institutional managers reported $349K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $-358 via N-PORT as of 2026-03-31.
Summary
- Issuer: CNS PHARMACEUTICALS INC
- Class: COM
- CUSIP: 18978H508
- Asset category: EC
- 13F holders: 9
- 13F value: $349K
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $-358
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| Stonepine Capital Management, LLC | Bend, OR | $146K | 61,000 |
| Ikarian Capital, LLC | DALLAS, TX | $110K | 45,830 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $56K | 23,189 |
| BOOTHBAY FUND MANAGEMENT, LLC | NEW YORK, NY | $32K | 13,524 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $3K | 1,310 |
| UBS Group AG | Zurich, V8 | $2K | 729 |
| BARRETT & COMPANY, INC. | PROVIDENCE, RI | $38 | 8 |
| MAI Capital Management | INDEPENDENCE, OH | $8 | 3 |
| DANSKE BANK A/S | COPENHAGEN V, G7 | $2 | 1 |
Top fund holders (N-PORT)
More